| Breakdown | TTM | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.54B | 47.61B | 47.67B | 47.02B | 45.53B | 39.48B |
| Gross Profit | 31.85B | 32.23B | 31.83B | 31.31B | 29.69B | 25.74B |
| EBITDA | 4.71B | 4.10B | 5.80B | 5.66B | 5.01B | 4.36B |
| Net Income | 2.90B | 52.00M | 3.55B | 1.83B | 4.11B | 1.88B |
Balance Sheet | ||||||
| Total Assets | 51.78B | 52.12B | 53.90B | 55.02B | 55.30B | 54.11B |
| Cash, Cash Equivalents and Short-Term Investments | 7.17B | 6.59B | 9.07B | 9.40B | 12.53B | 11.79B |
| Total Debt | 23.79B | 23.49B | 23.98B | 26.34B | 29.41B | 31.26B |
| Total Liabilities | 34.05B | 34.26B | 35.68B | 38.06B | 39.55B | 42.26B |
| Stockholders Equity | 17.66B | 17.75B | 18.14B | 16.96B | 15.75B | 11.84B |
Cash Flow | ||||||
| Free Cash Flow | 141.00M | -882.00M | 3.82B | 1.46B | 2.04B | 6.28B |
| Operating Cash Flow | 399.00M | 662.00M | 5.46B | 3.81B | 3.54B | 6.65B |
| Investing Cash Flow | 203.50M | -2.62B | -786.00M | -2.50B | -375.00M | -401.00M |
| Financing Cash Flow | -1.44B | -653.00M | -5.00B | -4.39B | -2.42B | 1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥30.34B | 5.63 | 21.87% | 2.14% | 15.35% | 45.10% | |
66 Neutral | ¥27.27B | 14.32 | 21.68% | 1.02% | 14.02% | 32.73% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥33.63B | 5.66 | ― | 2.48% | -4.39% | 31.40% | |
53 Neutral | ¥2.39B | 42.21 | ― | 1.19% | 6.83% | 1654.82% | |
52 Neutral | ¥10.23B | 5.24 | ― | 5.06% | 0.36% | 81.58% | |
41 Neutral | ¥2.22B | 11.92 | ― | ― | -6.45% | 99.39% |